We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00084656
Recruitment Status : Completed
First Posted : June 11, 2004
Last Update Posted : April 26, 2010
National Cancer Institute (NCI)
Information provided by:
Bristol-Myers Squibb